A transcriptomic model was trained for each RNA phenotype in each tissue. The table below includes models with cis-heritability P-value < 0.01, which were used for TWAS association testing. Thus, for single phenotype modalities such as expression level, there are 0 or 1 models per gene per tissue, while for multi-phenotype modalities such as isoform ratio, there may be multiple models per gene per tissue.
| Tissue | Modality | Sample size | Models |
|---|---|---|---|
| Adipose | alternative polyA | 411 | 3663 |
| Adipose | alternative TSS | 411 | 3373 |
| Adipose | gene expression | 411 | 9297 |
| Adipose | isoform ratio | 411 | 4631 |
| Adipose | intron excision ratio | 411 | 3180 |
| Adipose | mRNA stability | 411 | 4436 |
| BLA | alternative polyA | 191 | 2217 |
| BLA | alternative TSS | 191 | 1888 |
| BLA | gene expression | 191 | 6760 |
| BLA | isoform ratio | 191 | 3046 |
| BLA | intron excision ratio | 191 | 3324 |
| BLA | mRNA stability | 191 | 2434 |
| Brain | alternative polyA | 341 | 3697 |
| Brain | alternative TSS | 341 | 4026 |
| Brain | gene expression | 341 | 10088 |
| Brain | isoform ratio | 341 | 5623 |
| Brain | intron excision ratio | 341 | 6005 |
| Brain | mRNA stability | 341 | 5403 |
| Eye | alternative polyA | 53 | 297 |
| Eye | alternative TSS | 53 | 400 |
| Eye | gene expression | 53 | 1230 |
| Eye | isoform ratio | 53 | 580 |
| Eye | intron excision ratio | 53 | 919 |
| Eye | mRNA stability | 53 | 362 |
| IL | alternative polyA | 83 | 1103 |
| IL | alternative TSS | 83 | 653 |
| IL | gene expression | 83 | 4172 |
| IL | isoform ratio | 83 | 1256 |
| IL | intron excision ratio | 83 | 1121 |
| IL | mRNA stability | 83 | 1384 |
| LHb | alternative polyA | 82 | 1118 |
| LHb | alternative TSS | 82 | 604 |
| LHb | gene expression | 82 | 3691 |
| LHb | isoform ratio | 82 | 1275 |
| LHb | intron excision ratio | 82 | 1173 |
| LHb | mRNA stability | 82 | 1269 |
| Liver | alternative polyA | 411 | 2632 |
| Liver | alternative TSS | 411 | 2673 |
| Liver | gene expression | 411 | 7908 |
| Liver | isoform ratio | 411 | 3749 |
| Liver | intron excision ratio | 411 | 4840 |
| Liver | mRNA stability | 411 | 3066 |
| NAcc | alternative polyA | 430 | 3112 |
| NAcc | alternative TSS | 430 | 2807 |
| NAcc | gene expression | 430 | 8564 |
| NAcc | isoform ratio | 430 | 4286 |
| NAcc | intron excision ratio | 430 | 4949 |
| NAcc | mRNA stability | 430 | 3275 |
| OFC | alternative polyA | 82 | 1126 |
| OFC | alternative TSS | 82 | 713 |
| OFC | gene expression | 82 | 4196 |
| OFC | isoform ratio | 82 | 1352 |
| OFC | intron excision ratio | 82 | 1173 |
| OFC | mRNA stability | 82 | 1351 |
| PL | alternative polyA | 407 | 3296 |
| PL | alternative TSS | 407 | 3307 |
| PL | gene expression | 407 | 9284 |
| PL | isoform ratio | 407 | 4753 |
| PL | intron excision ratio | 407 | 5439 |
| PL | mRNA stability | 407 | 3880 |
| pVTA | alternative polyA | 153 | 1674 |
| pVTA | alternative TSS | 153 | 1336 |
| pVTA | gene expression | 153 | 5294 |
| pVTA | isoform ratio | 153 | 2250 |
| pVTA | intron excision ratio | 153 | 3006 |
| pVTA | mRNA stability | 153 | 1461 |
| RMTg | alternative polyA | 93 | 586 |
| RMTg | alternative TSS | 93 | 475 |
| RMTg | gene expression | 93 | 1833 |
| RMTg | isoform ratio | 93 | 661 |
| RMTg | intron excision ratio | 93 | 814 |
| RMTg | mRNA stability | 93 | 620 |